APA (7th ed.) Citation

M, H., S, S., B, O., I, N., H, K., N, K., . . . G, W. (2023). Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: A phase 1/2 single-blind, randomised controlled trial. Wellcome open research, 8, 182. https://doi.org/10.12688/wellcomeopenres.19150.2

Chicago Style (17th ed.) Citation

M, Hamaluba, et al. "Safety and Immunogenicity of ChAdOx1 NCoV-19 (AZD1222) Vaccine in Adults in Kenya: A Phase 1/2 Single-blind, Randomised Controlled Trial." Wellcome Open Research 8 (2023): 182. https://doi.org/10.12688/wellcomeopenres.19150.2.

MLA (9th ed.) Citation

M, Hamaluba, et al. "Safety and Immunogenicity of ChAdOx1 NCoV-19 (AZD1222) Vaccine in Adults in Kenya: A Phase 1/2 Single-blind, Randomised Controlled Trial." Wellcome Open Research, vol. 8, 2023, p. 182, https://doi.org/10.12688/wellcomeopenres.19150.2.